Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel D Ferrari

Showing results (21-30 of 275) with videos related to

Pageof 28
Sort By:
Current Opinion in Neurology|May 13, 2009
Neuroimaging in trigeminal autonomic cephalgias: when, how, and of what?Leopoldine A Wilbrink, Michel D Ferrari, Mark C Kruit, et al.
Pain|June 1, 1991
Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study GroupMichel D Ferrari, Marcia Wilkinson, Dorothea Hirt, et al.
Pain|April 26, 2020
Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control studyGerrit L J Onderwater, Jitze Dool, Michel D Ferrari, et al.
Brain : a Journal of Neurology|July 12, 2005
Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA studyMark C Kruit, Lenore J Launer, Michel D Ferrari, et al.
Current Treatment Options in Neurology|December 4, 2012
Familial and sporadic hemiplegic migraine: diagnosis and treatmentNadine Pelzer, Anine H Stam, Joost Haan, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 10, 2013
[Aura-related symptoms associated with cluster headache: outcomes of a LUCA substudy]L A Wilbrink, Carlo Cheung, Claudia M Weller, et al.
Stroke|February 25, 2006
Brain stem and cerebellar hyperintense lesions in migraineMark C Kruit, Lenore J Launer, Michel D Ferrari, et al.
Headache|July 2, 2013
Cluster-tic syndrome: a cross-sectional study of cluster headache patientsLeopoldine A Wilbrink, Claudia M Weller, Carlo Cheung, et al.
Cephalalgia : an International Journal of Headache|April 20, 2021
Time lost due to an attack - a novel patient-reported outcome measure for acute migraine treatmentsHeiko Pohl, Silvia Benemei, David Garcia-Azorin, et al.
CNS Drugs|January 31, 2020
Pharmacotherapy for Cluster HeadacheRoemer B Brandt, Patty G G Doesborg, Joost Haan, et al.
Pageof 28

Showing results (21-30 of 275) with videos related to

Sort By:
Pageof 28
Current Opinion in Neurology|May 13, 2009
Neuroimaging in trigeminal autonomic cephalgias: when, how, and of what?Leopoldine A Wilbrink, Michel D Ferrari, Mark C Kruit, et al.
Pain|June 1, 1991
Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study GroupMichel D Ferrari, Marcia Wilkinson, Dorothea Hirt, et al.
Pain|April 26, 2020
Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control studyGerrit L J Onderwater, Jitze Dool, Michel D Ferrari, et al.
Brain : a Journal of Neurology|July 12, 2005
Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA studyMark C Kruit, Lenore J Launer, Michel D Ferrari, et al.
Current Treatment Options in Neurology|December 4, 2012
Familial and sporadic hemiplegic migraine: diagnosis and treatmentNadine Pelzer, Anine H Stam, Joost Haan, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 10, 2013
[Aura-related symptoms associated with cluster headache: outcomes of a LUCA substudy]L A Wilbrink, Carlo Cheung, Claudia M Weller, et al.
Stroke|February 25, 2006
Brain stem and cerebellar hyperintense lesions in migraineMark C Kruit, Lenore J Launer, Michel D Ferrari, et al.
Headache|July 2, 2013
Cluster-tic syndrome: a cross-sectional study of cluster headache patientsLeopoldine A Wilbrink, Claudia M Weller, Carlo Cheung, et al.
Cephalalgia : an International Journal of Headache|April 20, 2021
Time lost due to an attack - a novel patient-reported outcome measure for acute migraine treatmentsHeiko Pohl, Silvia Benemei, David Garcia-Azorin, et al.
CNS Drugs|January 31, 2020
Pharmacotherapy for Cluster HeadacheRoemer B Brandt, Patty G G Doesborg, Joost Haan, et al.
Pageof 28